Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
01 6Omgene Life Sciences Pvt. Ltd
02 1Sanofi
03 43AbbVie Inc
04 16Orion Corporation
05 6Pharmathen SA
06 42care4 ApS
07 4Accure Labs
08 1Amneal Pharmaceuticals
09 9Astellas Pharma
10 1Aurobindo Pharma Limited
11 6Biological E
12 3Cross Pharma AB
13 1Endo International
14 4Eriochem S.A.
15 2Eurolab
16 4GP Pharm
17 4Health Biotech
18 1InvaGen Pharmaceuticals Inc
19 1Jodas Expoim Pvt. Ltd
20 3Key Oncologics
21 1McNeil Consumer Health
22 3Medartuum AB
23 1Meitheal Pharmaceuticals
24 5Mundipharma
25 4ORIFARM GROUP AS
26 2Omnia Pharmaceutical AB
27 1Paranova Läkemedel AB
28 4Pharmachim AB
29 2Pluviaendo
30 1RK Pharma
31 3Recordati
32 11Sandoz B2B
33 1Savior Lifetec Corporation
34 1Sun Pharmaceutical Industries Limited
35 4TOLMAR INTERNATIONAL LTD.
36 3Takeda Pharmaceutical
37 2Themis Medicare
38 2TherDose Pharma
39 5Tolmar
40 1UBI Pharma
41 2VERITY PHARMACEUTICALS INC.
42 2Varian Pharmed
01 1Depo.Inj
02 5Depot Injection
03 6Dry Sub
04 1FOR SUSPENSION;INTRAMUSCULAR
05 1IMP
06 7IMPLANT
07 1IMPLANT;IMPLANTATION
08 8INJ
09 2INJECTABLE, TABLET;INTRAMUSCULAR, ORAL
10 1INJECTABLE; INJECTION
11 7INJECTABLE;INJECTION
12 4INJECTION
13 3Implant
14 2Inj Prep
15 7Injection
16 2KIT
17 4LYOPHILIZED MICRO-SPHERES FOR INJECTION
18 1Leuprorelin 11,25Mg 1 Unit Parenteral Use
19 1Leuprorelin 22.5Mg 1 Unit Parenteral Use
20 1Leuprorelin 3,6Mg Plant Parenteral Use
21 1Leuprorelin 3,75Mg 1 Unit Parenteral Use Rp - Intramuscular
22 1Leuprorelin 3,75Mg 1 Unit Parenteral Use Rp - Intramuscular And Subcutaneous Use
23 1Leuprorelin 45Mg 1 Unit Parenteral Use
24 1Leuprorelin 5Mg Plant Parenteral Use
25 1Leuprorelin 7,5Mg 1 Unit Parenteral Use
26 6Long Acting Injectable
27 19POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
28 9POWDER FOR SUSPENSION, SUSTAINED-RELEASE
29 8POWDER;INTRAMUSCULAR
30 5POWDER;SUBCUTANEOUS
31 13PULVER OCH VÄTSKA TILL INJEKTIONSVÄTSKA
32 1Powder and liquid to depot injection fluid, suspension
33 3Powder and liquid to the injection fluid, resolution in the finished filled syringe
34 4Powder and liquid to the injection fluid, suspension
35 4Powder and liquid to the injection fluid, suspension in the finished filled syringe
36 4Powder and liquid to the injection fluid, suspension in two chamber syringe
37 6Pre Filled Syringe
38 2Pre-Filled Syringe
39 10SOLUTION;SUBCUTANEOUS
40 4Vial
41 13Blank
01 8DISCN
02 15Generic
03 3Originator
04 26RX
05 6USA
06 123Blank
01 17ELIGARD
02 4ELIGARD KIT
03 6Eligard
04 1Eligard 1 month
05 1Eligard 22.5mg
06 1Eligard 3 month
07 1Eligard 4 month
08 1Eligard 45mg
09 2Eligard 6 month
10 1Eligard 7.5mg
11 3Eligard thermo Traypa
12 2Enanton Depot
13 7Enanton Depot Dual
14 7Enanton Depot Set
15 4Enanton Pit Set
16 1Enantone Die
17 2Enantone Prefilled
18 1FENSOLVI KIT
19 4LECTRUM
20 9LEUPROLIDE ACETATE
21 1LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
22 1LEUPROLIDE HEXAL 5
23 2LUPANETA PACK
24 1LUPRON
25 13LUPRON DEPOT
26 8LUPRON DEPOT-PED KIT
27 2Leptoprol
28 1Leupromer 7.5
29 2Leuprorelin Cross Pharma
30 5Leuprorelin Sandoz
31 1Leuprostin
32 1Lucrin
33 1Lucrin 11.25
34 1Lucrin 3.75
35 1Lucrin Depot 3 Month PDS
36 1Lucrin Depot 4 Month PDS
37 1Lucrin Depot 6-Month
38 1Lucrin Depot 7.5mg PDS
39 3Lucrin Depot PDS
40 2Lucrin Depot Paediatric 30 mg PDS
41 1Lutrate Depot
42 1Palutor 11.25
43 1Palutor 3.75
44 3Politrate
45 1Prinolid 11,25
46 1Prinolid 3,75
47 8Procren Depot
48 1Prostap Depot
49 1VIADUR
50 2ZEULIDE DEPOT
51 1leuprorelin 2care4
52 1leuprorelin Pharmachim
53 2leuprorelin Sandoz
54 33Blank
01 4Argentina
02 11Australia
03 11Canada
04 6Greece
05 25India
06 2Iran
07 9Italy
08 19Norway
09 9South Africa
10 39Sweden
11 8Switzerland
12 1Taiwan
13 2Turkey
14 35USA
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Depot Injection
Dosage Strength : 3.75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEUPROLIDE ACETATE
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 14MG/2.8ML (1MG/0.2ML)
Packaging :
Approval Date : 2001-11-29
Application Number : 75721
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUPRON
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 14MG/2.8ML (1MG/0.2ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1985-04-09
Application Number : 19010
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Enanton Depot Dual
Dosage Form : PULVER OCH VÄTSKA TILL INJEKTIONSVÄTSKA
Dosage Strength : 30 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Long Acting Injectable
Dosage Strength : 3.75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Depot Injection
Dosage Strength : 7.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Depot Injection
Dosage Strength : 22.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Depot Injection
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Depot Injection
Dosage Strength : 45MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : LUPRON DEPOT
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 7.5MG
Packaging :
Approval Date : 1989-01-26
Application Number : 19732
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUPRON DEPOT
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 3.75MG
Packaging :
Approval Date :
Application Number : 19943
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUPRON DEPOT
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 3.75MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1990-10-22
Application Number : 20011
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUPRON DEPOT
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 3.75MG
Packaging :
Approval Date : 1995-10-26
Application Number : 20011
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUPRON DEPOT-PED KIT
Dosage Form : POWDER;INTRAMUSCULAR
Dosage Strength : 7.5MG
Packaging :
Approval Date : 1993-04-16
Application Number : 20263
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUPRON DEPOT-PED KIT
Dosage Form : POWDER;INTRAMUSCULAR
Dosage Strength : 3.75MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1993-04-16
Application Number : 20263
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUPRON DEPOT-PED KIT
Dosage Form : POWDER;INTRAMUSCULAR
Dosage Strength : 7.5MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1993-04-16
Application Number : 20263
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUPRON DEPOT-PED KIT
Dosage Form : POWDER;INTRAMUSCULAR
Dosage Strength : 11.25MG
Packaging :
Approval Date : 1994-01-21
Application Number : 20263
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUPRON DEPOT-PED KIT
Dosage Form : POWDER;INTRAMUSCULAR
Dosage Strength : 15MG
Packaging :
Approval Date : 1994-01-21
Application Number : 20263
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUPRON DEPOT-PED KIT
Dosage Form : POWDER;INTRAMUSCULAR
Dosage Strength : 11.25MG
Packaging :
Approval Date : 2011-08-15
Application Number : 20263
Regulatory Info : RX
Registration Country : USA
